Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the potential benefits of platelet-rich plasma (PRP) for treating androgenic alopecia in athletes and examines how physical activity might influence androgen levels, but it reports no new results.

This study provides evidence that intralesional platelet-rich plasma therapy leads to significant hair regrowth and increased patient satisfaction in individuals with scalp alopecia areata over 24 weeks, without notable adverse effects.

This review analyzes Platelet-Rich Plasma therapy for facial aesthetics, discussing its principles, efficacy, safety, and future research directions, but reports no new clinical results.

This abstract pertains to a dermatology-related academic profile without reporting any specific study findings. Results or research details are not provided.

This study found that combining platelet-rich plasma with 4% hydroquinone was more effective in reducing melasma symptoms than using hydroquinone alone.

This study found that platelet-rich plasma therapy may be a useful alternative to 5% topical minoxidil for treating androgenetic alopecia, with differences in the effectiveness and patient satisfaction outcomes observed.

This study reported that in patients with androgenic alopecia, platelet-rich plasma therapy's effectiveness in enhancing hair density and caliber was positively correlated with specific growth factor concentrations, notably glial cell-derived neurotrophic factor and platelet-derived growth factor-BB, while no significant correlations were found with demographic factors.

This study found that both single- and double-spin PRP preparation methods significantly increased thrombocyte counts and improved hair parameters in males with androgenetic alopecia, with the single-spin method showing a more significant increase in thrombocyte count.

This article reports a case of herpes zoster ophthalmicus following platelet-rich plasma treatment for androgenic alopecia and emphasizes adhering to guidelines to ensure safe outcomes.

This review found mixed evidence regarding platelet-rich plasma's effectiveness in various medical applications, noting significant limitations like small sample sizes and lack of standardization that necessitate further research.

This review found that platelet-rich plasma treatment is effective for androgenetic alopecia, significantly increasing hair diameter in both sexes, but only improving hair density in men.

In this study, researchers found that platelet-rich plasma therapy demonstrated significantly higher efficacy than topical minoxidil for treating androgenetic alopecia in a Pakistani population, with a 91.7% negative hair pull rate compared to 69.4% for minoxidil after 12 weeks.

This review discusses the potential of platelet-rich plasma therapy as an adjunctive treatment for pediatric surgical wound care and reports no new clinical results, highlighting the need for more controlled trials.

This review discusses platelet-rich plasma (PRP) therapy for pediatric surgical wound care, evaluating its potential as an adjunctive treatment, but reports no new clinical results.

This meta-analysis found that PRP monotherapy improved hair density in androgenetic alopecia patients but did not affect hair diameter, with stronger effects observed in male subjects.

This study found that platelet-rich plasma therapy was highly effective for patients with mild to moderate androgenic alopecia, showing promise as a cost-effective and safe treatment option.

PRP injections are more effective than triamcinolone for treating alopecia areata.

This review suggests that combining PRP with minoxidil may be more effective for promoting hair growth in androgenetic alopecia than using either treatment alone, although study variations limit definitive conclusions.

This review concluded that the double-spin PRP preparation method may be more effective than the single-spin technique for treating androgenetic alopecia.

This study found that intralesional triamcinolone acetonide is more effective and faster than platelet-rich plasma in promoting hair regrowth for scalp alopecia areata.

This study found that Platelet Rich Plasma treatment may safely and effectively promote hair regrowth in patients with pattern hair loss, especially when combined with other topical drugs like finasteride and minoxidil.

This meta-analysis found that platelet-rich plasma therapy significantly increased hair density in androgenic alopecia, with stand-alone PRP showing notable improvements, but the benefits of combining PRP with other therapies remain uncertain.

In this randomized controlled trial, PRP combined with redensyl, saw palmetto, and biotin showed superior efficacy in improving androgenetic alopecia grading scores in male patients when compared to PRP with Procapil.

In this study, PRP treatment improved hair loss in 40 female patients with female pattern alopecia, with most progressing to better grades of hair coverage after 6 months, while only minor pain was occasionally reported as an adverse effect.

This study suggests that platelet-rich plasma is a safe and effective treatment for alopecia areata, showing superior treatment response compared to triamcinolone acetonide and placebo, with primarily minor side effects.

This article highlights that research is currently indicating platelet-rich plasma therapy as a promising treatment for certain types of baldness, addressing the psychological impact of alopecia.

This study reported improvements in hair count and shaft diameter following PRP treatment for androgenetic alopecia, yet concluded it is not an evidence-based therapy for hair loss.

In this study, minoxidil combined with PRP was found to effectively increase hair density in women with female pattern hair loss, but showed no superiority over minoxidil alone. No major side effects were reported.

This case study reported significant hair regrowth in a 67-year-old woman with telogen effluvium following SARS-CoV-2 infection after treatment with a combination of active agents, laser therapies, and medications.

In this case study, a 29-year-old man with alopecia areata experienced satisfactory hair regrowth after five months of combined intralesional triamcinolone acetonide and platelet-rich plasma therapy.